P

Pulike Biological Engineering Inc
SSE:603566

Watchlist Manager
Pulike Biological Engineering Inc
SSE:603566
Watchlist
Price: 13.05 CNY -2.25%
Market Cap: 4.5B CNY
Have any thoughts about
Pulike Biological Engineering Inc?
Write Note

Pulike Biological Engineering Inc
Free Cash Flow

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Pulike Biological Engineering Inc
Free Cash Flow Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Free Cash Flow CAGR 3Y CAGR 5Y CAGR 10Y
P
Pulike Biological Engineering Inc
SSE:603566
Free Cash Flow
ÂĄ84.8m
CAGR 3-Years
27%
CAGR 5-Years
9%
CAGR 10-Years
N/A
H
Hansoh Pharmaceutical Group Company Ltd
HKEX:3692
Free Cash Flow
ÂĄ2.9B
CAGR 3-Years
44%
CAGR 5-Years
11%
CAGR 10-Years
N/A
Zhangzhou Pientzehuang Pharmaceutical Co Ltd
SSE:600436
Free Cash Flow
ÂĄ1.1B
CAGR 3-Years
52%
CAGR 5-Years
-6%
CAGR 10-Years
22%
Jiangsu Hengrui Pharmaceuticals Co Ltd
SSE:600276
Free Cash Flow
ÂĄ6.3B
CAGR 3-Years
64%
CAGR 5-Years
17%
CAGR 10-Years
17%
Yunnan Baiyao Group Co Ltd
SZSE:000538
Free Cash Flow
ÂĄ4.4B
CAGR 3-Years
-11%
CAGR 5-Years
N/A
CAGR 10-Years
14%
S
Sichuan Biokin Pharmaceutical Co Ltd
SSE:688506
Free Cash Flow
-ÂĄ697.3m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
No Stocks Found

Pulike Biological Engineering Inc
Glance View

Market Cap
4.5B CNY
Industry
Pharmaceuticals

Pulike Biological Engineering, Inc. engages in the research, development, manufacturing and sale of biological products for animals, chemical drugs and Chinese veterinary drugs. The company is headquartered in Luoyang, Henan and currently employs 1,809 full-time employees. The company went IPO on 2015-05-18. Inc is principally engaged in the research, development, production and distribution of veterinary biological products and chemical medicines. The firm's veterinary biological products include vaccine and antibody, applied in the prevention and controlling of infection to epidemic disease for poultry and livestock. Its veterinary chemical medicines are mainly used in the treatment of epidemic diseases of poultry and livestock.

Intrinsic Value
21.18 CNY
Undervaluation 38%
Intrinsic Value
Price
P

See Also

What is Pulike Biological Engineering Inc's Free Cash Flow?
Free Cash Flow
84.8m CNY

Based on the financial report for Sep 30, 2024, Pulike Biological Engineering Inc's Free Cash Flow amounts to 84.8m CNY.

What is Pulike Biological Engineering Inc's Free Cash Flow growth rate?
Free Cash Flow CAGR 5Y
9%

The average annual Free Cash Flow growth rates for Pulike Biological Engineering Inc have been 27% over the past three years , 9% over the past five years .

Back to Top